Navigation Links
New Blood Clot Removal System Successfully Restores Blood Flow

PARK CITY, Utah, July 25, 2013 /PRNewswire-iReach/ -- Dr. Nick Cavros, interventional cardiologist with Cardiovascular Institute of the South (CIS) at Lafayette General Medical Center in Lafayette, Louisiana, used a new hand-held mechanical aspiration system to remove blood clots and increase blood flow.


The patented ASPIRE Aspirator connects to any aspiration catheter and aspirates, or sucks out, blood clots in blocked arteries and veins.  ASPIRE systems allow clinicians to instantly start, stop, increase, decrease, or pulse aspiration during a variety of procedures. 

During the procedure, which takes place in a catheterization laboratory, a small catheter is inserted into the patient's leg and is guided to the blocked vessel.  Once a catheter is in the vein or artery, the cardiologist can diagnose the location and extent of the lesion.  Treatment options vary depending on the age, size, and location of the blood clot.  Clinicians may follow blood clot aspiration with stent, bypass, or other intervention. 

"Most people know that blood clots are lethal in the heart and brain.  But, blood clots can be life-threatening in the legs, lung, and other organs too," said Dr. Cavros.  "Our CIS team has experience treating a wide range of blood clots with numerous tools.  We focus on the patient's needs and tailor the right therapy to improve care—fast."

Blood clot aspiration is typically performed with basic syringes or electromechanical pumps.  Basic syringes require two hands to operate, are volume limited, and do not maintain consistent aspiration force.  Electromechanical systems can aspirate more volume with increased force, but are expensive, can be difficult to use, require extensive set-up, and do not give the clinician tactile feedback during aspiration. 

"Speed and accuracy is important to remove blood clots and restore blood flow," continued Dr. Cavros.  "The ASPIRE system improves aspiration speed and performance, and it allows us to use a variety of catheters specific to the patient's needs." 

"We are pleased that our technology was used again to improve patient care," said Shawn Fojtik, CEO of Control Medical Technology.  "Improving aspiration can improve care.  The ASPIRE Aspirator meets this challenge with a simple technology to improve aspiration speed and control."       

CIS is one of the most respected groups of cardiologists, representing nearly every specialty in heart and circulatory medicine.  With a team of nearly 500 dedicated team members, CIS serves communities throughout Louisiana, as well as national and international patients, at its 14 clinics.  CIS consistently positions itself at the forefront of technology by providing the most up-to-date technology coupled with compassionate care.  This mission has guided the institute for nearly 30 years of service to south Louisiana.  For more information about CIS, call 1-800-425-2565 or visit

Control Medical Technology designs, develops, and markets innovative blood clot (thrombus) management, biopsy, and aspiration devices, including the patented ASPIRE Thrombus Aspirator, patented ASPIRE MAX Thrombus Aspiration Catheter Systems, and other devices to improve patient care.  For more information about Control Medical, call 1-954-9345 or visit

Cardiovascular Institute of the South Media contact:

Anne Kolwe, Marketing Director

Phone: (985) 872-5980

Fax: (985) 851-0780


Control Medical Media contact: 

Carolina Vance

(954) 457-2450

Media Contact: Shawn Fojtik, Control Medical Technology, 4356029640,

News distributed by PR Newswire iReach:

SOURCE Control Medical Technology
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. SynGen Hires Former Pall Medical Executive as President of Cord Blood Business Unit
2. SynGen Inc. Receives FDA 510K Clearance to Market SynGenX-1000 Cord Blood Processing Platform
3. Global Blood Pressure Monitor Market 2012-2016: High Competition among Vendors Could Pose a Challenge to Growth of this Market
4. Lexicon Presents Data at the American Diabetes Association Meeting On Blood Pressure Reduction and Weight Loss In Clinical Trial of LX4211
5. Phase III study finds investigational agent empagliflozin significantly reduced blood glucose in adults with type 2 diabetes and impaired kidney function
6. Phase III studies show linagliptin improved blood glucose control in Asian adults with type 2 diabetes
7. Phase III data show investigational compound empagliflozin significantly reduced blood glucose in adults with type 2 diabetes
8. Phase III data show significant reduction in blood glucose with investigational compound empagliflozin added to metformin or metformin plus sulfonylurea in adults with type 2 diabetes
9. Celebrating 25 Years and Counting: Leukemia and Lymphoma Societys "Team In Training" Goes the Distance and Beyond for Blood Cancer Patients
10. "Blood Therapy" Has Patients Flocking to Washington DCs Pioneering Pain Doctor
11. Inostics Blood-based Mutation Testing Receives CLIA Certification
Post Your Comments:
(Date:12/1/2015)... 1, 2015 Building on its 25-year ... Johnson (NYSE: JNJ ) today announced four ... to significantly reduce the burden of HIV incidence, ... percent of new HIV infections among adolescents in ... Day, these new initiatives include collaborations with the ...
(Date:12/1/2015)... York , December 1, 2015 /PRNewswire/ ... Pills, Contraceptive Injectables, Topical Contraceptives, Male Condoms, ... Contraceptive Vaginal Rings, Contraceptive Diaphragms, Contraceptive Sponges, ... Analysis, Size, Share, Growth, Trends and Forecast ... by Transparency Market Research (TMR).The report states ...
(Date:12/1/2015)... ATLANTA , Dec. 1, 2015   ... automated value cycle solutions, today announced the company ... Pharmacy ChargeLink ® solution at ... 2015 Midyear Clinical Meeting . The new features ... complicated process of monitoring and managing enterprise-wide pharmacy ...
Breaking Medicine Technology:
(Date:12/1/2015)... FL (PRWEB) , ... December 01, 2015 , ... ... announces the Multi Jar, a container patent that allows for easier packing and organizing ... the US is worth $90 billion," says Scott Cooper, CEO and Creative Director of ...
(Date:12/1/2015)... ... ... Hospital Tampa is the first health care provider in the region to offer the ... is a vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult ... least 40 to 45 kg, or a BMI of at least 35 to 39.9 kg ...
(Date:12/1/2015)... Houston, TX (PRWEB) , ... December 01, 2015 , ... ... owner of Vitenas Cosmetic Surgery, has been named by MedEsthetics magazine as the Best ... best of the best among the many elite aesthetic physicians honored by the industry ...
(Date:12/1/2015)... Delaware (PRWEB) , ... December 01, 2015 , ... ... winner at the 7th Annual 2015 Golden Bridge Business Awards under the New ... is a zero capex web based sample management software that helps ...
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays ... film for accurate interpretation by the radiologist. The marking utensils are so small, ... Calif., has found a way to alleviate this problem. , He developed the ...
Breaking Medicine News(10 mins):